BofA Upgrades Schrödinger (SDGR) to Buy After Strategic Pivot to Software
Schrödinger, Inc. (NASDAQ:SDGR) is one of the best healthcare AI stocks to buy now. On December 15, BofA Securities upgraded Schrödinger, Inc.
Schrodinger Inc. (SDGR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 4,171,498 | $74,586,384 | -21% | 0.89% |
| 2. | ARK Investment Management Catherine D. Wood | 2,111,829 | $37,759,501 | +13% | 0.25% |
| 3. | 1,357,900 | $24,279,252 | +25% | 0.05% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 80,774 | $1,444,239 | +110% | 0% |
| 5. | Royce & Associates Chuck Royce | 29,009 | $518,681 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.90 | 1,115 | $111,385.94 | 0 | 2021-02-05 | Filing | |
| $17.00 | 588,235 | $9,999,995.00 | 6,981,664 | 2020-02-10 | Filing | |
| $17.00 | 250,000 | $4,250,000.00 | 250,000 | 2020-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.80 | 776 | $10,705.39 | 22,859 | 2026-02-10 | Filing | |
| $13.73 | 925 | $12,703.77 | 52,651 | 2026-02-10 | Filing | |
| $13.79 | 752 | $10,370.38 | 26,597 | 2026-02-10 | Filing | |
| $13.51 | 1,230 | $16,617.30 | 19,385 | 2026-02-09 | Filing | |
| $21.07 | 1,395 | $29,387.07 | 24,574 | 2025-10-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,517,096 | $170,165,678 | 0% | |
| 2. | 6,464,426 | $115,583,937 | 0% | |
| 3. | 4,714,767 | $84,300,034 | 0.05% | |
| 4. | 3,717,890 | $66,475,873 | 0.01% | |
| 5. | 2,819,670 | $50,359,306 | 0.58% |
News See All
11 Best Healthcare AI Stocks to Buy Now
On August 13, 2025, the World Economic Forum (WEF) published an analysis exploring how AI is transforming healthcare.
Schrödinger, Inc. (NASDAQ:SDGR) Q3 2025 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Schrodinger's conference call to review third quarter 2025 financial results. My name is Rob, and I'll be your operator for today's call.
Bill Gates’s Stock Portfolio: Top 15 Stock Picks
Bill Gates’s disciplined and long-term investment philosophy is reflected in the investment strategy of the Bill & Melinda Gates Foundation Trust, which manages the endowment supporting one of the world...
Schrödinger, Inc. (NASDAQ:SDGR) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to Schrodinger's conference call to review second quarter 2025 financial results. My name is Rob, and I'll be your operator for today's call.
Citi Affirms Buy Rating on Schrödinger (SDGR) amid Expanded Collaboration with Ajax Therapeutics
Schrödinger, Inc. (NASDAQ:SDGR) is one of the top 10 medical AI companies to buy according to analysts. On July 17, analysts at Citi reiterated a ‘Buy’ rating on the stock and a $39 price target.
Top 10 Medical AI Companies to Buy According to Analysts
Artificial intelligence is transforming medical sciences in ways not seen before.
Morgan Stanley Assumes Coverage on Schrödinger (SDGR) Stock
Schrödinger, Inc. (NASDAQ:SDGR) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds
As per the US Bank, the healthcare in the US exhibits a large and intricate ecosystem, which is characterized by size, complexity, and influence on the broader national economy.
Hedge Fund Resource Center Billionaire Hedge Funds
